BackTcr2 Therapeutics Overview

Tcr2 Therapeutics Research & Development

Research & Development expenses for TCRR.

Quarterly R&D Expenses

$29.27M
↑ 27.89% YoY

As of Mar 31, 2023

Annual R&D Expenses (TTM)

$105.56M
↑ 25.37% YoY

Trailing 12 months ending Mar 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin